Report Overview: The Global Acute Repetitive Seizures Market achieved a valuation of $296.07 Million in 2022 and is anticipated to exceed $6561.67 Million by 2030, reflecting a compounded annual growth rate (CAGR) of 47.3% during the forecast period from 2024 to 2032. Key Market Players: Alexza Pharmaceuticals, Bausch Health, Neurelis, Pfizer Inc., Sanofi, UCB S.A.,Valeant...